CD274 and neoplasm: As observed on day 11 post-treatment, tumor growth was similar in the vehicle group and in mice treated with the isotype control antibodies (a control for the anti-PD-L1) while administration of anti-PD-L1 itself produced a small but not statistically significant (p = 0.0702) decrease in tumor growth by 35%.